Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Ischemic Stroke

doi:10.3969/j.issn.1673-5765.2023.12.004

Abstract

Abstract: The treatment of ischemic stroke in acute phase has always been a highly discussed topic. In the seven years since the publication of the 2016 edition of the national clinical guideline for stroke for the United Kingdom and Ireland, there have been significant developments in reperfusion therapy for acute ischemic stroke patients. The 2023 edition of the guidelines updated some recommendations on the acute phase treatment of ischemic stroke based on the 2016 edition. This paper will provide an interpretation of the key update points in the 2023 edition and compare them with the 2019 American Heart Association (AHA) /American Stroke Association (ASA) guidelines for the early management of patients with acute ischemic stroke, and The Chinese Clinical Management Guidelines for Cerebrovascular Diseases (2nd Edition) published in 2023.

Key words: Acute ischemic stroke; Guideline recommendation; Reperfusion therapy

摘要： 缺血性卒中的急性期治疗一直是备受关注的话题。英国国家卒中临床指南2016版推出7年来，急性缺血性卒中患者的再灌注已经有了很大的治疗进展以及研究突破，基于这些进展，英国国家卒中临床指南2023版在2016版的基础上，对缺血性卒中的急性期治疗方案进行了部分推荐意见的更新。本文对2023版指南的更新要点进行解读，并与2019年出版的美国心脏学会/美国卒中学会急性缺血性卒中早期管理指南及2023年出版的《中国脑血管病临床管理指南（第2版）》中的推荐进行了对比。

关键词: 急性缺血性卒中; 指南推荐; 再灌注治疗

HAO Manjun, CAO Zhixin, LI Guangshuo, XIONG Yunyun. Interpretation of the Keypoints and Updates on National Clinical Guideline for Stroke for the United Kingdom and Ireland (Edition 2023) —Ischemic Stroke[J]. Chinese Journal of Stroke, 2023, 18(12): 1357-1364.

郝曼均, 曹智鑫, 李光硕, 熊云云. 英国国家卒中临床指南2023版要点及解读——缺血性卒中[J]. 中国卒中杂志, 2023, 18(12): 1357-1364.

References

[1] MENON B K，BUCK B H，SINGH N，et al. Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada（AcT）：a pragmatic，multicentre，open-label，registry-linked，randomised，controlled，non-inferiority trial[J]. Lancet，2022，400（10347）：161-169.
[2] WANG Y，LI S，PAN Y，et al. Tenecteplase versus alteplase in acute ischaemic cerebrovascular events（TRACE-2）：a phase 3，multicentre，open-label，randomised controlled，non-inferiority trial[J]. Lancet，2023，401（10377）：645-654.
[3] POWERS W J，RABINSTEIN A A，ACKERSON T，et al. Guidelines for the early management of patients with acute ischemic stroke：2019 update to the 2018 guidelines for the early management of acute ischemic stroke：a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J/OL]. Stroke，2019，50（12）：e344-e418[2023-07-05]. https://doi.org/10.1161/STR.0000000000000211.
[4] 刘丽萍，周宏宇，段婉莹，等. 中国脑血管病临床管理指南（第2版）（节选）——第4章缺血性脑血管病临床管理推荐意见[J]. 中国卒中杂志，2023，18（8）：910-933.
LIU L P，ZHOU H Y，DUAN W Y，et al. Chinese stroke association guidelines for clinical management of cerebrovascular diseases（second edition）（excerpt）—chapter four clinical management of ischaemic cerebrovascular diseases[J]. Chin J Storke，2023，18（8）：910-933.
[5] THOMALLA G，SIMONSEN C Z，BOUTITIE F，et al. MRI-guided thrombolysis for stroke with unknown time of onset[J]. N Engl J Med，2018，379（7）：611-622.
[6] MA H，CAMPBELL B C V，PARSONS M W，et al. Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke[J]. N Engl J Med，2019，380（19）：1795-1803.
[7] ALBERS G W，CAMPBELL B C，LANSBERG M G，et al. Efficacy and safety of tenecteplase in patients with late-window acute ischaemic stroke and evidence of salvageable tissue：results from the phase Ⅲ TIMELESS trial[J/OL]. Eur Stroke J，2023，2_suppl（8）：670-711[2023-07-05]. https://doi.org/10.1177/23969873231174267.
[8] YANG P F，ZHANG Y W，ZHANG L，et al. Endovascular thrombectomy with or without intravenous alteplase in acute stroke[J]. N Engl J Med，2020，382（21）：1981-1993.
[9] ZI W J，QIU Z M，LI F L，et al. Effect of endovascular treatment alone vs intravenous alteplase plus endovascular treatment on functional independence in patients with acute ischemic stroke：the DEVT randomized clinical trial[J]. JAMA，2021，325（3）：234-243.
[10] SUZUKI K，MATSUMARU Y，TAKEUCHI M，et al. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke：the SKIP randomized clinical trial[J]. JAMA，2021，325（3）：244-253.
[11] LECOUFFE N E，KAPPELHOF M，TREURNIET K M，et al. A randomized trial of intravenous alteplase before endovascular treatment for stroke[J]. N Engl J Med，2021，385（20）：1833-1844.
[12] FISCHER U，KAESMACHER J，STRBIAN D，et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke：an open-label，blinded-outcome，randomised non-inferiority trial[J]. Lancet，2022，400（10346）：104-115.
[13] MITCHELL P J，YAN B，CHURILOV L，et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4.5 h of stroke onset：an open-label，blinded-endpoint，randomised non-inferiority trial[J]. Lancet，2022，400（10346）：116-125.
[14]] MAJOIE C B，CAVALCANTE F，GRALLA J，et al. Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke：individual participant data meta-analysis of six randomised trials[J]. Lancet，2023，402（10406）：965-974.
[15] YOSHIMURA S，SAKAI N，YAMAGAMI H，et al. Endovascular therapy for acute stroke with a large ischemic region[J]. N Engl J Med，2022，386（14）：1303-1313.
[16] SARRAJ A，HASSAN A E，ABRAHAM M G，et al. Trial of endovascular thrombectomy for large ischemic strokes[J]. N Engl J Med，2023，388（14）：1259-1271.
[17] HUO X C，MA G T，TONG X，et al. Trial of endovascular therapy for acute ischemic stroke with large infarct[J]. N Engl J Med，2023，388（14）：1272-1283.
[18] LIU X F，DAI Q L，YE R D，et al. Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion（BEST）：an open-label，randomised controlled trial[J]. Lancet Neurol，2020，19（2）：115-122.
[19] TAO C R，NOGUEIRA R G，ZHU Y Y，et al. Trial of endovascular treatment of acute basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1361-1372.
[20] JOVIN T G，LI C H，WU L F，et al. Trial of thrombectomy 6 to 24 hours after stroke due to basilar-artery occlusion[J]. N Engl J Med，2022，387（15）：1373-1384.
[21] ZHAO Z A，QIU J，WANG L，et al. Intra-arterial tenecteplase is safe and may improve the first-pass recanalization for acute ischemic stroke with large-artery atherosclerosis：the BRETIS-TNK trial[J/OL]. Front Neurol，2023，14：1155269[2023-07-05]. https://doi.org/10.3389/fneur.2023.1155269.
[22] XIONG Y Y，CAMPBELL B C V，FISHER M，et al. Rationale and design of Tenecteplase Reperfusion Therapy in Acute Ischaemic Cerebrovascular Events Ⅲ（TRACE Ⅲ）：a randomised，phase Ⅲ，open-label，controlled trial[J/OL]. Stroke Vasc Neurol，2023，29：svn-2023-002310[2023-07-05]. http://dx.doi.org/10.1136/svn-2023-002310.